| To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days (NCT00300677) | Pfizer | 2007-03-01 |
| Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics (NCT00645463) | Pfizer | 2007-03-01 |
| Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail (NCT01278394) | Pfizer | 2007-03-01 |
| A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease (NCT00455000) | Pfizer | 2007-03-01 |
| Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women. (NCT00443027) | Pfizer | 2007-03-01 |
| Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers (NCT00452894) | Pfizer | 2007-03-01 |
| Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms (NCT00408954) | Pfizer | 2007-03-01 |
| Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)). (NCT00443248) | Pfizer | 2007-03-01 |
| A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure (NCT00422461) | Pfizer | 2007-02-27 |
| Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults (NCT00427895) | Pfizer | 2007-02-27 |
| Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis (NCT00413699) | Pfizer | 2007-02-05 |
| Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety. (NCT00396448) | Pfizer | 2007-02-01 |
| Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer (NCT00393939) | Pfizer | 2007-02-01 |
| A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks (NCT00427401) | Pfizer | 2007-02-01 |
| Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan) (NCT00666276) | Pfizer | 2007-02-01 |
| Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer (NCT00372996) | Pfizer | 2007-02-01 |
| Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors (NCT00447005) | Pfizer | 2007-02-01 |
| Observational Study Of Donepezil In Routine Clinical Practice (NCT00843115) | Pfizer | 2007-02-01 |
| Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma (NCT00425061) | Pfizer | 2007-02-01 |
| A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors (NCT00879554) | Pfizer | 2007-02-01 |
| Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma (NCT00494091) | Pfizer | 2007-02-01 |
| SUTENT® In The First Line Treatment Of Renal Cell Carcinoma (NCT00460798) | Pfizer | 2007-02-01 |
| Maraviroc in Rheumatoid Arthritis (NCT00427934) | Pfizer | 2007-02-01 |
| A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer (NCT00435409) | Pfizer | 2007-02-01 |
| Cumulative Irritation Test (NCT00680095) | Pfizer | 2007-01-22 |
| A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients (NCT00445315) | Pfizer | 2007-01-01 |
| A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain (NCT00418782) | Pfizer | 2007-01-01 |
| The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events (NCT01052948) | Pfizer | 2007-01-01 |
| Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis (NCT00413660) | Pfizer | 2007-01-01 |
| A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients (NCT00425100) | Pfizer | 2007-01-01 |
| Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis (NCT00409175) | Pfizer | 2007-01-01 |
| Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease. (NCT00430300) | Pfizer | 2007-01-01 |
| An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis (NCT00383188) | Pfizer | 2006-12-15 |
| PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine (NCT00437203) | Pfizer | 2006-12-01 |
| Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer (NCT00389441) | Pfizer | 2006-12-01 |
| Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy (NCT00346268) | Pfizer | 2006-12-01 |
| Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain (NCT00415597) | Pfizer | 2006-12-01 |
| Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain (NCT01117766) | Pfizer | 2006-12-01 |
| The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms (NCT00401245) | Pfizer | 2006-12-01 |
| Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature (NCT00396097) | Pfizer | 2006-12-01 |
| A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee (NCT00420992) | Pfizer | 2006-12-01 |
| Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive (NCT00372424) | Pfizer | 2006-12-01 |
| A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® (NCT00391027) | Pfizer | 2006-12-01 |
| A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo (NCT00365924) | Pfizer | 2006-12-01 |
| A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog® (NCT00356421) | Pfizer | 2006-11-01 |
| A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers (NCT00392080) | Pfizer | 2006-11-01 |
| Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033 (NCT00376285) | Pfizer | 2006-11-01 |
| Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents (NCT00387725) | Pfizer | 2006-11-01 |
| Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors (NCT00424632) | Pfizer | 2006-11-01 |
| A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting (NCT00488488) | Pfizer | 2006-11-01 |
| A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine (NCT00373113) | Pfizer | 2006-11-01 |
| A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients (NCT00391196) | Pfizer | 2006-11-01 |
| A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer (NCT00373256) | Pfizer | 2006-11-01 |
| Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria. (NCT00367653) | Pfizer | 2006-11-01 |
| Study for Evaluating Different Methods of Measuring Depression Treatment Response (NCT00406952) | Pfizer | 2006-11-01 |
| A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis (NCT00393835) | Pfizer | 2006-11-01 |
| A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors (NCT00528619) | Pfizer | 2006-11-01 |
| [S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain. (NCT00354094) | Pfizer | 2006-11-01 |
| A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases (NCT00360464) | Pfizer | 2006-10-01 |
| Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia (NCT00463372) | Pfizer | 2006-10-01 |
| Methods Study to Characterize Early Indicators of Weight Loss in People (NCT00383253) | Pfizer | 2006-10-01 |
| A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety (NCT00375401) | Pfizer | 2006-10-01 |
| A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents (NCT00389519) | Pfizer | 2006-10-01 |
| Open-label Extension Study Of RN624 (NCT00399490) | Pfizer | 2006-09-15 |
| Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer (NCT00338884) | Pfizer | 2006-09-01 |
| An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking (NCT00371813) | Pfizer | 2006-09-01 |
| A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus (NCT00367445) | Pfizer | 2006-09-01 |
| Colombia Epidemiologic Surveillance Study (NCT00428051) | Pfizer | 2006-09-01 |
| PH-797804 LPS Study in Healthy Volunteers (NCT02084485) | Pfizer | 2006-09-01 |
| Observational Trial With Enbrel (NCT00488475) | Pfizer | 2006-09-01 |
| Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine (NCT00373958) | Pfizer | 2006-09-01 |
| Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule (NCT00460486) | Pfizer | 2006-09-01 |
| A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults (NCT00360295) | Pfizer | 2006-09-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder (NCT00384033) | Pfizer | 2006-09-01 |
| Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer (NCT00321308) | Pfizer | 2006-09-01 |
| [S,S]-Reboxetine Add-On Trial (NCT00334685) | Pfizer | 2006-08-22 |
| Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery (NCT00838383) | Pfizer | 2006-08-10 |
| A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia (NCT00357825) | Pfizer | 2006-08-01 |
| Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media (NCT00360100) | Pfizer | 2006-08-01 |
| Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer (NCT00321815) | Pfizer | 2006-08-01 |
| Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development (NCT00401232) | Pfizer | 2006-08-01 |
| Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration (NCT01245387) | Pfizer | 2006-08-01 |
| Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause (NCT00314964) | Pfizer | 2006-08-01 |
| Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration (NCT00460408) | Pfizer | 2006-08-01 |
| Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer (NCT00291577) | Pfizer | 2006-07-01 |
| An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD (NCT00327470) | Pfizer | 2006-07-01 |
| Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions (NCT00324116) | Pfizer | 2006-07-01 |
| Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan) (NCT01660334) | Pfizer | 2006-07-01 |
| Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension (NCT00355589) | Pfizer | 2006-07-01 |
| Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults (NCT00331175) | Pfizer | 2006-07-01 |
| Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety (NCT00359801) | Pfizer | 2006-07-01 |
| A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency (NCT00308464) | Pfizer | 2006-07-01 |
| Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis (NCT00445770) | Pfizer | 2006-07-01 |
| Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes. (NCT00326326) | Pfizer | 2006-07-01 |
| A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain. (NCT00353808) | Pfizer | 2006-07-01 |
| [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy. (NCT00348894) | Pfizer | 2006-07-01 |
| Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis (NCT00680134) | Pfizer | 2006-06-30 |
| Study of Different Doses of a Novel Treatment for Onychomycosis (NCT00679770) | Pfizer | 2006-06-30 |
| Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes (NCT00348374) | Pfizer | 2006-06-01 |
| Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity (NCT00367783) | Pfizer | 2006-06-01 |